Myocarditis in the Setting of Recent COVID-19 Vaccination | Zendy

Laura Onderko | Zendy; Benjamin Starobin | Zendy; Amy Riviere | Zendy; Patrick Hohl | Zendy; Colin T. Phillips | Zendy; Róisín B. Morgan | Zendy; Aimee Welsh | Zendy; Sanjeev Francis | Zendy; Maxwell Eyram Afari | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Myocarditis in the Setting of Recent COVID-19 Vaccination

Author(s) -

Laura Onderko,

Benjamin Starobin,

Amy Riviere,

Patrick Hohl,

Colin T. Phillips,

Róisín B. Morgan,

Aimee Welsh,

Sanjeev Francis,

Maxwell Eyram Afari

Publication year - 2021

Publication title -

case reports in cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.106

H-Index - 5

eISSN - 2090-6412

pISSN - 2090-6404

DOI - 10.1155/2021/6806500

Subject(s) - covid-19 , myocarditis , medicine , vaccination , biomarker , presentation (obstetrics) , chest pain , cardiology , intensive care medicine , immunology , virology , radiology , disease , biology , biochemistry , outbreak , infectious disease (medical specialty)

We report three patients who presented with chest pain after receiving either the BNT162b2 Pfizer/BioNTech or mRNA-1273 Moderna/NIH vaccine. Clinical presentation, biomarker, and cardiac MRI supported myocarditis. It is imperative that potential side effects of COVID-19 vaccine are reported to improve our knowledge about COVID-19 and mRNA vaccines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research